Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

BUSINESS DEVELOPMENT has been a key term for IPIX and Leo over the past 6 months or so. If you read several of the last Q's you will find a bold titled section under Managements Plan of Operation and you will find bolded "BUSINESS DEVELOPMENT ACTIVITIES"

Over the past months I have read emails to other shareholders from the company and Leo dropped "Business Development" in the majority of them. When shareholders asked what is the plan and what is the delay with P and all of the hard questions, his response was mostly "actively" working with the CRO but the majority of our time is Business Development efforts. As I read more and more it came to me after I read this snip from the Q that Business Development basically meant partnerships and moving the business along with collaborations.

Business Development Activities

The Company is engaged in discussions and negotiations regarding the out-licensing of its mid-stage, first-in-class clinical assets to global and/or specialty pharmaceutical companies who have expressed an interest in one or more assets in our pipeline. Successfully securing partnerships would afford the Company access to immediate and potentially recurring sources of non-dilutive capital, including upfront fees, milestone-based payments and tiered royalties.


Recently, we released results from our completed Phase 2 Brilacidin study on Oral Mucositis. The results have attracted inquiries, additional confidential disclosure agreements, and discussions with pharmaceutical companies.